Replies to post #335058 on Amarin Corp Plc (AMRN)

[couldbebetter]

I don't know. What I don't understand is if Thero's retirement was
planned well in advance then why not have an event to introduce the
new CEO? Then the question was he recruited for the purpose of:
A. Being the new President & CEO of Amarin.
B. Being the head of operations in Europe.
C. Being the head of operations in Europe to facilitate a BP BO.

Maybe his promotion to CEO is to highlight the importance of Europe
to the future of AMRN. If AMRN is to GIA Europe will be the biggest
driver of revenues and growth for AMRN. AMRN remains a one drug
company with a limited commercial life so a sale of the company
remains the most logical outcome. Could AMRN acquire new drugs
to have its sales force sell? Sure, but that has not (yet) been
the case. Why hire a massive sales force to only sell one product?
It is more logical to sell the company to BP which has the sales
force already in place. Thero has paid lip service for product
diversification yet it never happened. (Nor did a sale of the company.)

My hope is still for a sale as it is the most logical end game. If
not a BO then is Mikhail the right man to build AMRN into a BP? I don't
know, but I think he will do an excellent job in Europe.

[raistthemage]

I'm not in a hurry to come back in any case. JT left a big hole to dig out from... if the new CEO immediately launches an authorized generic with TEVA I'll reconsider.

I'll mostly stick to making money via selling covered calls on MARA in any case... the stock is unstable as hell but I'm up on it and the covered call premiums are around 20% on calls a good amount out of the money in 45 days.